Clinical trial

A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With…

NCT00447603 · Organon and Co, Industry · Terminated

Key facts

NCT number NCT00447603
Title A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)
Official title A Randomized, Double-Blind, Active Comparator Study to Evaluate the Antihypertensive Efficacy and Safety of Losartan/HCTZ Combination as Compared to Losartan Monotherapy in Pediatric Patients With Essential Hypertension
Lead sponsor Organon and Co, Industry
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Hypertension
Intervention type Drug
Interventions hydrochlorothiazide (+) losartan potassium, losartan potassium, Placebo for Losartan, Placebo for Losartan/HCTZ
Enrollment 40
Start date May 24, 2007
Primary completion Oct 22, 2007
Completion Oct 22, 2007
First posted Mar 15, 2007
Last update posted Jun 18, 2024

At a glance

  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies